David Bom
Impact in
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 10%
Papers in ⓘ
-
- Fluorine in Organic Chemistry 2
- Co-authors
- Dennis P. Curran (9 shared papers)David A. Jacques (1 shared paper)John E. Anthony (1 shared paper)Mark S. Meier (1 shared paper)Bailin Chen (1 shared paper)Rodney Andrews (1 shared paper)John P. Selegue (1 shared paper)Thomas G. Burke (7 shared papers)
- Journals
- Annals of the New York Academy of Sciences (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (2 papers)Journal of the American Chemical Society (1 paper)Journal of Controlled Release (1 paper)
- Partner nations
- United States
In The Last Decade
David Bom
15 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 82
- Toxicology 128
- Organic Chemistry 262
- Oncology 241
- Materials Chemistry 325
- Molecular Biology 480
Countries citing papers authored by David Bom
This map shows the geographic impact of David Bom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bom more than expected).
Fields of papers citing papers by David Bom
This network shows the impact of papers produced by David Bom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bom. The network helps show where David Bom may publish in the future.
Co-authors
The 25 scholars most cited alongside David Bom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 426 | |
| 2 | 2000 | 133 | |
| 3 | 1998 | 120 | |
| 4 | 2004 | 70 | |
| 5 | 1999 | 62 | |
| 6 | 1997 | 50 | |
| 7 | Potent topoisomerase I inhibition by novel silatecans eliminates glioma proliferation in vitro and in vivo. | 1999 | 50 |
| 8 | 2001 | 47 | |
| 9 | 2002 | 40 | |
| 10 | 2000 | 35 | |
| 11 | 2012 | 30 | |
| 12 | 2000 | 17 | |
| 13 | Affinity of new anticancer agent, DB-174, to membranes and HSA determined by fluorescence spectroscopy methods | 2006 | 2 |
| 14 | 1998 | 2 | |
| 15 | 2000 | 1 |
About David Bom
David Bom is a scholar working on Toxicology, Pharmaceutical Science, Oncology, Pharmacology and Molecular Biology, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (11 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Neutropenia and Cancer Infections (3 papers), Synthetic Organic Chemistry Methods (2 papers), Cancer Treatment and Pharmacology (2 papers), Synthesis and Biological Evaluation (2 papers), DNA and Nucleic Acid Chemistry (2 papers) and Fluorine in Organic Chemistry (2 papers). The work is most often cited by research in Toxicology (128 citations), Organic Chemistry (262 citations), Oncology (241 citations), Materials Chemistry (325 citations) and Molecular Biology (480 citations). David Bom has collaborated with scholars based in United States. Frequent co-authors include Dennis P. Curran, David A. Jacques, John E. Anthony, Mark S. Meier, Bailin Chen, Rodney Andrews, John P. Selegue, Thomas G. Burke, Hubert Josien and Sung‐Bo Ko. Their work appears in journals such as Annals of the New York Academy of Sciences, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of the American Chemical Society and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.